These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8619449)
41. Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia. Mekonnen SK; Medhin G; Berhe N; Clouse RM; Aseffa A Malar J; 2015 Aug; 14():317. PubMed ID: 26271736 [TBL] [Abstract][Full Text] [Related]
42. A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Sowunmi A Ann Trop Med Parasitol; 2002 Apr; 96(3):227-38. PubMed ID: 12061970 [TBL] [Abstract][Full Text] [Related]
43. [Therapeutic effect of pyronaridine in plain tablets and enteric-coated tablets in falciparum malaria patients]. Huang ZS; Feng Z; Meng F; Zeng LH; Lin X; Zheng Y; Xing QF; Guo RN Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1989; 7(1):19-21. PubMed ID: 2670309 [TBL] [Abstract][Full Text] [Related]
45. A comparative study of artesunate and artemether in combination with mefloquine on multidrug resistant falciparum malaria in eastern Thailand. Thimasarn K; Sirichaisinthop J; Chanyakhun P; Palananth C; Rooney W Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):465-71. PubMed ID: 9561593 [TBL] [Abstract][Full Text] [Related]
46. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Noedl H; Krudsood S; Chalermratana K; Silachamroon U; Leowattana W; Tangpukdee N; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Sriwichai S; Rowan J; Bhattacharyya H; Ohrt C; Knirsch C Clin Infect Dis; 2006 Nov; 43(10):1264-71. PubMed ID: 17051490 [TBL] [Abstract][Full Text] [Related]
47. Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria. Jiao X; Liu GY; Shan CO; Zhao X; Li XW; Gathmann I; Royce C Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):476-81. PubMed ID: 9561595 [TBL] [Abstract][Full Text] [Related]
48. Pyronaridine against multiresistant falciparum malaria. Peters W Lancet; 1996 Mar; 347(9001):625. PubMed ID: 8596361 [No Abstract] [Full Text] [Related]
49. Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population. Hagos B; Khan B; Ofulla AV; Kariuki D; Martin SK East Afr Med J; 1993 Oct; 70(10):620-3. PubMed ID: 8187656 [TBL] [Abstract][Full Text] [Related]
50. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Vugt MV; Wilairatana P; Gemperli B; Gathmann I; Phaipun L; Brockman A; Luxemburger C; White NJ; Nosten F; Looareesuwan S Am J Trop Med Hyg; 1999 Jun; 60(6):936-42. PubMed ID: 10403324 [TBL] [Abstract][Full Text] [Related]
51. In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine. Pradines B; Mabika Mamfoumbi M; Parzy D; Owono Medang M; Lebeau C; Mourou Mbina JR; Doury JC; Kombila M Am J Trop Med Hyg; 1999 Jan; 60(1):105-8. PubMed ID: 9988332 [TBL] [Abstract][Full Text] [Related]
52. Effect of arteether alpha/beta on uncomplicated falciparum malaria cases in Upper Assam. Mohapatra PK; Khan AM; Prakash A; Mahanta J; Srivastava VK Indian J Med Res; 1996 Nov; 104():284-7. PubMed ID: 8979518 [TBL] [Abstract][Full Text] [Related]
53. The effects of pyronaridine on the morphology of Plasmodium falciparum in Aotus trivirgatus. Kawai S; Kano S; Chang C; Suzuki M Am J Trop Med Hyg; 1996 Aug; 55(2):223-9. PubMed ID: 8780465 [TBL] [Abstract][Full Text] [Related]
54. [In vitro sensitivity of Plasmodium falciparum isolates from China-Myanmar border region to chloroquine, piperaquine and pyronaridine]. Zhang CL; Zhou HN; Wang J; Liu H Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Feb; 30(1):41-4. PubMed ID: 22913189 [TBL] [Abstract][Full Text] [Related]
55. Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections. Ringwald P; Bickii J; Same-Ekobo A; Basco LK Antimicrob Agents Chemother; 1997 Oct; 41(10):2317-9. PubMed ID: 9333075 [TBL] [Abstract][Full Text] [Related]
56. Synergism between pyronaridine and retinol in Plasmodium falciparum in vitro. Proell P; Congpuong K; Reinthaler FF; Wernsdorfer G; Wiedermann U; Wernsdorfer WH Wien Klin Wochenschr; 2009 Oct; 121 Suppl 3():32-6. PubMed ID: 19915814 [TBL] [Abstract][Full Text] [Related]
57. Predictive score of uncomplicated falciparum malaria patients turning to severe malaria. Tangpukdee N; Krudsood S; Thanachartwet V; Duangdee C; Paksala S; Chonsawat P; Srivilairit S; Looareesuwan S; Wilairatana P Korean J Parasitol; 2007 Dec; 45(4):273-82. PubMed ID: 18165709 [TBL] [Abstract][Full Text] [Related]
58. Clinical efficacy of a tea-bag formulation of cryptolepis sanguinolenta root in the treatment of acute uncomplicated falciparum malaria. Bugyei KA; Boye GL; Addy ME Ghana Med J; 2010 Mar; 44(1):3-9. PubMed ID: 21326984 [TBL] [Abstract][Full Text] [Related]
59. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria. Pryce J; Taylor M; Fox T; Hine P Cochrane Database Syst Rev; 2022 Jun; 6(6):CD006404. PubMed ID: 35726133 [TBL] [Abstract][Full Text] [Related]